Gene · 407026
Papers3,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Stiff Side of Cancer: How Matrix Mechanics Rewrites Non-Coding RNA Expression Programs. | Noncoding RNA | 2026 | 41745140 | PubTator, text mining | PubMed |
| Extracellular vesicles and their role in Lupus Nephritis: A scoping review. | J Transl Autoimmun | 2026 | 41732236 | PubTator, text mining | PubMed |
| Epigenetics in B-CLL. | Int J Genomics | 2026 | 41716484 | PubTator, text mining | PubMed |
| Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma. | Leukemia | 2026 | 41714403 | PubTator, text mining | PubMed |
| Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. | JCO Precis Oncol | 2026 | 41712875 | PubTator, text mining | PubMed |
| Glioma Cell-Derived Apoptotic Extracellular Vesicles Promote Tumorigenesis and Temozolomide Resistance by Delivering LncRNA-XIST. | J Biochem Mol Toxicol | 2026 | 41693519 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the impact of concurrent, resistance, and endurance training on skeletal muscle. | PLoS One | 2026 | 41637404 | PubTator, text mining | PubMed |
Collaborative breakthroughs in precision diagnosis and treatment of nasopharyngeal cancer: Biomarker‑driven screening and endoscopic minimally invasive surgery reshape the new paradigm of early intervention (Review). | Oncol Rep | 2026 | 41574726 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Epigenetic alterations in rotator cuff tendinopathy and degenerative cuff tears: a systematic review. | JSES Rev Rep Tech | 2026 | 41536319 | PubTator, text mining | PubMed |
| A combination of Mycobacterium tuberculosis-derived sRNA and endogenous miRNA in circulation as novel auxiliary diagnostic markers for patients with multidrug-resistant tuberculosis. | J Glob Antimicrob Resist | 2026 | 41519265 | PubTator, text mining | PubMed |
| [Expression of Concern] MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA. | Mol Med Rep | 2026 | 41456438 | PubTator, text mining | PubMed |
| Mechanism of exercise-derived circulating exosomes as a target for sarcopenia management. | Front Physiol | 2025 | 41659924 | PubTator, text mining | PubMed |
| Retraction of: The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma. | Aging (Albany NY) | 2025 | 41348537 | PubTator, text mining | PubMed |
| Successful Delivery of Small Non-Coding RNA Molecules into Human iPSC-Derived Lung Spheroids in 3D Culture Environment. | Biomedicines | 2025 | 41153702 | PubTator, text mining | PubMed |
| Conformational change-based electrochemical biosensor for the simple and highly selective detection of miRNA in whole serum. | RSC Adv | 2025 | 41140497 | PubTator, text mining | PubMed |
| MicroRNAs and lung cancer: overview of essential pathways and somatic mutations in cancer progression. | Front Oncol | 2025 | 41127014 | PubTator, text mining | PubMed |
| Plasma multi-omics and machine learning reveal predictive biomarkers for type 2 diabetes and retinopathy in Qatar biobank cohort. | J Transl Med | 2025 | 41126335 | PubTator, text mining | PubMed |
A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. | Cell Commun Signal | 2025 | 41039499 | PubTator, text mining | PubMed |
| Bio fluid exosomes: promises, challenges, and future directions in translational medicine. | J Transl Med | 2025 | 40988065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407026/papers?page=2